Vertex Pharmaceuticals ( VRTX 2.53%) has long been known as the company to turn to for life-saving cystic fibrosis (CF) drugs ...

Q4 2024 Earnings Call Transcript February 10, 2025 Vertex Pharmaceuticals Incorporated misses on earnings expectations. Reported EPS is $3.98 EPS, expectations were $4.02. Operator: Good day, and ...

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.

The cost-efficient model dubbed Gemini 2.0 Flash-Lite comes as a successor to the Gemini 1.5 Flash while sticking to the same ...

Announced in December, 2.0 Flash Thinking rivals OpenAI's o1 and o3-mini reasoning models in that it's capable of working ...

Vertex has wisely incorporated advances made by other innovative companies, too. For example, it partnered with CRISPR ...

Vertex Pharmaceuticals (NASDAQ ... One is the company's efforts to make the drug affordable, for example, offering a savings program that allows eligible patients to pay as little as $30 dollars ...

Meet suzetrigine, a non-opioid that promises to avoid addiction risk. But some experts say it can't replace opioids ...

The winners, Nathan Gates, Faith Apostolodes, and Kevin Helm have shared some insights as to what inspired their winning ...

Google also released an experimental version of Gemini 2.0 Pro, the company’s flagship model with the best performance for ...

Vertex valuation multiples have reached unsustainable heights at ~11x forward revenue, which increases its risk for a correction. Vertex specializes in corporate tax compliance software, targeting ...